ADVERTISEMENT

Comments?
Help us improve Portfolio Grader.


Comments?
Help us improve Portfolio Grader.


Blue Chip Growth

Stock Report: AmSurg Corp. (AMSG) Report Updated: Apr 21, 2014 | Print This Page

Get more stock ratings by Louis Navellier

AmSurg Corp. (AMSG)

Rating: Buy Volatility: Conservative
Total Grade: B Industry: Health Care Providers & Services
Competitors: MCK, PRSC, EXAM, AIQ

Stock Analysis

Rating: Monthly View

A
B
C
D
F
April May June July August September October November December January February March

Rating: Weekly View

This Week: B down no change
Last Week: B same no change
Two Weeks Ago: B up no change
service keys

AmSurg Corp.© quotemedia

Company Profile

AmSurg Corp., through its subsidiaries, engages in the development, acquisition, and operation of ambulatory surgery centers (ASC) in partnership with physicians in the United States. The company’s surgery centers perform colonoscopy and other endoscopy procedures in the areas of gastroenterology; cataracts and retinal laser surgeries in the area of ophthalmology; and knee and shoulder arthroscopy and carpal tunnel repair in the area of orthopedics. As of December 31, 2011, it operated 228 ASCs in 35 states and the District of Columbia of the United States, including 146 centers for gastrointestinal endoscopy procedures, 36 centers for ophthalmology surgery procedures, 39 multi-specialty centers, and 7 centers for orthopaedic procedures. AmSurg Corp. provides its surgery center services directly to patients; and referring physicians and third-party payors, such as health maintenance organizations, preferred provider organizations, other managed care organizations, and employers. The company was founded in 1992 and is headquartered in Nashville, Tennessee.

Recent News: AmSurg Corp.